1317 related articles for article (PubMed ID: 30787102)
21. The nucleation growth and reversibility of Amyloid-beta deposition in vivo.
Dolev I; Michaelson DM
J Alzheimers Dis; 2006 Nov; 10(2-3):291-301. PubMed ID: 17119294
[TBL] [Abstract][Full Text] [Related]
22. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
23. APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques.
Kalback W; Watson MD; Kokjohn TA; Kuo YM; Weiss N; Luehrs DC; Lopez J; Brune D; Sisodia SS; Staufenbiel M; Emmerling M; Roher AE
Biochemistry; 2002 Jan; 41(3):922-8. PubMed ID: 11790115
[TBL] [Abstract][Full Text] [Related]
24. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer's disease amyloid-β pathology in the lens of the eye.
Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
[TBL] [Abstract][Full Text] [Related]
26. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
27. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
28. Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.
Möhle L; Israel N; Paarmann K; Krohn M; Pietkiewicz S; Müller A; Lavrik IN; Buguliskis JS; Schott BH; Schlüter D; Gundelfinger ED; Montag D; Seifert U; Pahnke J; Dunay IR
Acta Neuropathol Commun; 2016 Mar; 4():25. PubMed ID: 26984535
[TBL] [Abstract][Full Text] [Related]
29. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.
Rosen RF; Tomidokoro Y; Farberg AS; Dooyema J; Ciliax B; Preuss TM; Neubert TA; Ghiso JA; LeVine H; Walker LC
Neurobiol Aging; 2016 Aug; 44():185-196. PubMed ID: 27318146
[TBL] [Abstract][Full Text] [Related]
30. The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer's Disease.
Bugrova AE; Strelnikova PA; Indeykina MI; Kononikhin AS; Zakharova NV; Brzhozovskiy AG; Barykin EP; Pekov SI; Gavrish MS; Babaev AA; Kosyreva AM; Morozova AY; Degterev DA; Mitkevich VA; Popov IA; Makarov AA; Nikolaev EN
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008451
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of amyloid beta (Aβ) peptides - a trigger for formation of toxic aggregates in Alzheimer's disease.
Kumar S; Walter J
Aging (Albany NY); 2011 Aug; 3(8):803-12. PubMed ID: 21869458
[TBL] [Abstract][Full Text] [Related]
32. Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.
Cerpa W; Dinamarca MC; Inestrosa NC
Curr Alzheimer Res; 2008 Jun; 5(3):233-43. PubMed ID: 18537540
[TBL] [Abstract][Full Text] [Related]
33. Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes.
Hubin E; Deroo S; Schierle GK; Kaminski C; Serpell L; Subramaniam V; van Nuland N; Broersen K; Raussens V; Sarroukh R
Cell Mol Life Sci; 2015 Dec; 72(24):4899-913. PubMed ID: 26190022
[TBL] [Abstract][Full Text] [Related]
34. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
35. Nascent Aβ42 Fibrillization in Synaptic Endosomes Precedes Plaque Formation in a Mouse Model of Alzheimer's-like β-Amyloidosis.
Eckman EA; Clausen DM; Solé-Domėnech S; Lee CW; Sinobas-Pereira C; Domalewski RJ; Nichols MR; Pacheco-Quinto J
J Neurosci; 2023 Dec; 43(50):8812-8824. PubMed ID: 37884349
[TBL] [Abstract][Full Text] [Related]
36. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail.
Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR
ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450
[TBL] [Abstract][Full Text] [Related]
38. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.
Berson A; Knobloch M; Hanan M; Diamant S; Sharoni M; Schuppli D; Geyer BC; Ravid R; Mor TS; Nitsch RM; Soreq H
Brain; 2008 Jan; 131(Pt 1):109-19. PubMed ID: 18056160
[TBL] [Abstract][Full Text] [Related]
39. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
40. TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer's disease.
Shih YH; Tu LH; Chang TY; Ganesan K; Chang WW; Chang PS; Fang YS; Lin YT; Jin LW; Chen YR
Nat Commun; 2020 Nov; 11(1):5950. PubMed ID: 33230138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
